A phase I trial of the safety, tolerance, and pharmacokinetics of oral nelfinavir (Viracept) co-administered with zidovudine (ZDV) and lamivudine (3TC) in HIV infected pregnant women and their infants

Trial Profile

A phase I trial of the safety, tolerance, and pharmacokinetics of oral nelfinavir (Viracept) co-administered with zidovudine (ZDV) and lamivudine (3TC) in HIV infected pregnant women and their infants

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Lamivudine/zidovudine (Primary) ; Nelfinavir (Primary) ; Lamivudine; Zidovudine
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top